Lu Tian

415 total citations
17 papers, 277 citations indexed

About

Lu Tian is a scholar working on Molecular Biology, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lu Tian has authored 17 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Urology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lu Tian's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (3 papers) and Urinary Bladder and Prostate Research (3 papers). Lu Tian is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (3 papers) and Urinary Bladder and Prostate Research (3 papers). Lu Tian collaborates with scholars based in China, United States and Macao. Lu Tian's co-authors include Andrew Quitadamo, Xinghua Shi, Shasha Tao, Jielin Sun, Surui Yao, Zhaohui Huang, Siqun L. Zheng, Yuyang Feng, Jianfeng Xu and Kaisa Cui and has published in prestigious journals such as Oncogene, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Lu Tian

14 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lu Tian China	10	188	63	47	27	24	17	277
Yoshifumi Morimoto Japan	6	171 0.9×	38 0.6×	31 0.7×	9 0.3×	27 1.1×	8	261
Yuanjie Niu China	8	147 0.8×	71 1.1×	58 1.2×	5 0.2×	32 1.3×	12	243
Dominic B. Bernkopf Germany	11	351 1.9×	43 0.7×	34 0.7×	5 0.2×	27 1.1×	15	422
Kotaro Kasahara Japan	7	187 1.0×	101 1.6×	141 3.0×	10 0.4×	22 0.9×	18	333
Ryo Yamashita Japan	8	120 0.6×	75 1.2×	58 1.2×	37 1.4×	13 0.5×	40	375
Jianzhong Lin China	8	158 0.8×	84 1.3×	44 0.9×	10 0.4×	70 2.9×	13	294
Lu Yi China	10	269 1.4×	154 2.4×	75 1.6×	2 0.1×	19 0.8×	15	359
Louise A Diver United Kingdom	9	284 1.5×	252 4.0×	34 0.7×	8 0.3×	32 1.3×	11	432
Maxime Parisotto Canada	8	140 0.7×	60 1.0×	54 1.1×	3 0.1×	29 1.2×	17	242

Countries citing papers authored by Lu Tian

Since Specialization

Citations

This map shows the geographic impact of Lu Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Tian more than expected).

Fields of papers citing papers by Lu Tian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Tian. The network helps show where Lu Tian may publish in the future.

Co-authorship network of co-authors of Lu Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Tian. A scholar is included among the top collaborators of Lu Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Tian. Lu Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Tian, Lu, et al.. (2026). Development of a near-infrared fluorescent probe for visualizing of hypochlorous acid in vitro and in vivo. Talanta. 302. 129433–129433.

Gong, Liang, Lu Tian, Li He, et al.. (2025). FK228 reshapes tumor microenvironment to enhance anti-PD-L1 efficacy. Oncogene. 44(39). 3665–3678.

Tian, Lu, et al.. (2024). Tumor microenvironment-regulated nanoplatform for enhanced chemotherapy, cuproptosis and nonferrous ferroptosis combined cancer therapy. Journal of Materials Chemistry B. 13(3). 1089–1099.

Gong, Liang, Lu Tian, Kaisa Cui, et al.. (2023). An off-the-shelf small extracellular vesicle nanomedicine for tumor targeting therapy. Journal of Controlled Release. 364. 672–686. 24 indexed citations

An, Ni, Jie Zhang, Fan Mo, et al.. (2023). De novo genes with an lncRNA origin encode unique human brain developmental functionality. Nature Ecology & Evolution. 7(2). 264–278. 35 indexed citations

Tian, Lu, Liang Gong, Yuyang Feng, et al.. (2023). ELOA promotes tumor growth and metastasis by activating RBP1 in gastric cancer. Cancer Medicine. 12(18). 18946–18959. 2 indexed citations

Wang, Xue, Han Cheng, Jing Zhao, et al.. (2022). Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer. Molecular Cancer. 21(1). 210–210. 36 indexed citations

Quitadamo, Andrew, et al.. (2015). An integrated network of microRNA and gene expression in ovarian cancer. BMC Bioinformatics. 16(S5). S5–S5. 22 indexed citations

Tian, Lu, Andrew Quitadamo, Frederick T. J. Lin, & Xinghua Shi. (2014). Methods for population-based eQTL analysis in human genetics. Tsinghua Science & Technology. 19(6). 624–634. 12 indexed citations

10.

Wang, Hongqiang, Zhiwei He, Hui Fu, et al.. (2013). Deuterium-depleted water (DDW) inhibits the proliferation and migration of nasopharyngeal carcinoma cells in vitro. Biomedicine & Pharmacotherapy. 67(6). 489–496. 22 indexed citations

11.

Qi, Jun, Lu Tian, Zhuo Chen, et al.. (2013). Genetic Variants in 2q31 and 5p15 Are Associated With Aggressive Benign Prostatic Hyperplasia in a Chinese Population. The Prostate. 73(11). 1182–1190. 9 indexed citations

12.

Han, Yan, Li Wang, Shasha Tao, et al.. (2013). HDAC9 gene is associated with stroke risk in a Chinese population. Experimental Biology and Medicine. 238(7). 842–847. 15 indexed citations

13.

Na, Rong, Tao Huang, Li Wang, et al.. (2013). SRD5A1andSRD5A2are Associated with Treatment for Benign Prostatic Hyperplasia with the Combination of 5α-Reductase Inhibitors and α-Adrenergic Receptor Antagonists. The Journal of Urology. 190(2). 615–619. 19 indexed citations

14.

Tian, Lu, et al.. (2013). Video Based Children's Social Behavior Classification in Peer-Play Scenarios. 3. 770–774. 2 indexed citations

15.

Jiao, Yang, Li Wang, Shasha Tao, et al.. (2013). LILRA3 Is Associated with Benign Prostatic Hyperplasia Risk in a Chinese Population. International Journal of Molecular Sciences. 14(5). 8832–8840. 7 indexed citations

16.

Ma, Zhicheng, Qingfeng Hu, Zhuo Chen, et al.. (2012). Systematic evaluation of bladder cancer risk‐associated single‐nucleotide polymorphisms in a chinese population. Molecular Carcinogenesis. 52(11). 916–921. 39 indexed citations

17.

Wu, Lina, Zhixin Li, Yingmei Zhang, et al.. (2008). Adenovirus-expressed human hyperplasia suppressor gene induces apoptosis in cancer cells. Molecular Cancer Therapeutics. 7(1). 222–232. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact